Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2010
08/26/2010US20100216841 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists
08/26/2010US20100216836 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/26/2010US20100216813 Pyrrolidineanilines
08/26/2010US20100216806 Ortho aminoamides for the treatment of cancer
08/26/2010US20100216793 Heteroaryl substituted pyridazinone derivatives
08/26/2010US20100216785 Pharmaceutical compositions
08/26/2010US20100216772 Novel Phenantridine Analogues and Uses Thereof
08/26/2010US20100216769 Substituted glycinamides, process for their manufacture and use thereof as medicaments
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100215741 Pharmaceutical compounds
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010CA2752807A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010CA2751777A1 Novel ortho-aminoamides for the treatment of cancer
08/26/2010CA2749495A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/25/2010EP2220090A1 Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein
08/25/2010EP2220076A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220066A1 Benzofuran anilide histone deacetylase inhibitors
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/25/2010EP2220046A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220045A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
08/25/2010EP2220042A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
08/25/2010EP2220041A1 Synthesis of quaternary salt compounds
08/25/2010EP2219629A1 Novel compounds as cannabinoid receptor ligands
08/25/2010EP1871758B1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
08/25/2010EP1742912B1 Novel androgens
08/25/2010EP1737844B1 Bicyclic anthranilamide derivatives useful as insecticides
08/25/2010EP1620082B9 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
08/25/2010EP1481679B1 Antidepressant
08/25/2010EP0883403B1 Method for treating sexual dysfunctions
08/25/2010CN1972917B Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
08/25/2010CN101815710A Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
08/25/2010CN101812055A Compound and method applying same for fluorescence detection of activity of monoamine oxidase
08/25/2010CN101812013A 8-oxy-8H-acenaphtho[1,2-b]pyrrole derivative and application thereof
08/25/2010CN101812007A Aminopyrrole compound and preparation method thereof
08/25/2010CN101318938B Method for synthesizing quinoxaline derivant
08/25/2010CN101210011B Quinolines compounds and their intermediates, preparation method and application
08/24/2010US7781482 pyrolidone derivatives useful in the treatment of vision defects such as such as post-operative gaucoma, ocular hypertensive episodes, glaucoma, presurgical adjuncts or increased intraocular pressure
08/24/2010US7781456 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc.
08/24/2010US7781436 such as 1-Benzyl-2-methyl-1H-indol-3-yl)-(4-phenyl-piperidin-1-yl)-methanone, vasopressin (V1a) receptor antagonists, for the treatment of dysmenorrhea, hypertension, congestive heart failure, inappropriate secretion of vasopressin, cirrhosis, nephrosis, obsessive compulsive disorder and as anxiolytics
08/24/2010US7781435 (S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoic acid {1-[2-(3-ethoxy-propylamino) -ethyl]-1H-imidazol-4-yl}-amide, having beta-amyloid peptide production inhibitory activity, used for the treatment of neurodegenerative disorders such as Alzheimer's disease
08/24/2010CA2467857C Piperidine-based mch antagonists for treatment of obesity and cns disorders
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2010093419A1 Novel amino azaheterocyclic carboxamides
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092154A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010091721A1 3 -substituted 1-arylsulfonylpiperidine derivatives for the treatment of pain
08/19/2010WO2010091540A1 A sulphonyl tetrazole compound, its preparation method and its use for preparing laetispicine
08/19/2010WO2010074607A3 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
08/19/2010WO2010039534A3 Viral and fungal inhibitors
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210693 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/19/2010US20100210661 Stat3/5 activation inhibitor
08/19/2010US20100210657 Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210467 Agent for improving sugarcane brix and method of promoting sugarcane ripening using the same
08/19/2010US20100210466 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,6-diones and cyclohexanetriones as novel herbicides
08/19/2010US20100210036 Ppar active compounds
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2751886A1 Novel amino azaheterocyclic carboxamides
08/18/2010EP2218720A1 2-2'-Bis-thiazole derivatives as antiviral agents
08/18/2010EP2217592A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto
08/18/2010EP2217583A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
08/18/2010EP2217573A1 Treating and preventing viral infections
08/18/2010EP2217572A1 Isoquinoline modulators of atp-binding cassette transporters
08/18/2010EP2217569A1 Enantioselective process for preparing a substituted alkanoic acid
08/18/2010EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP2076495B1 Quinoline derivatives with 5-ht-binding properties
08/18/2010EP1984350B1 Pyrimidine derivatives used as pi-3 kinase inhibitors
08/18/2010EP1874761B1 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
08/18/2010EP1758857B1 Indole derivatives as antiviral agents
08/18/2010EP1692109B1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
08/18/2010EP1631561B1 Compositions and methods for non-invasive imaging of soluble beta-amyloid
08/18/2010EP1611107B1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
08/18/2010EP1578423B1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN101809001A Imidazole derivatives
08/18/2010CN101808999A Quinoline derivatives as 5HT5A receptor antagonists
08/18/2010CN101808997A Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast
08/18/2010CN101808996A Nicotinamide derivatives, preparation thereof and therapeutic use thereof
08/18/2010CN101808991A Acyclic derivatives as modulators of chemokine receptor activity
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101805330A 2-alkyl-benzimidazole-1-acetyl hydrazone and synthesis method and application thereof
08/18/2010CN101805329A 1,5-dual-substituted hexahydrotriazine compounds with insecticidal activity and preparation method thereof
08/18/2010CN101805328A epothilone derivatives
08/18/2010CN101805324A Cyclic carbonate compound and synthesis method thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 694